CLINICAL_TRIALS
trial_result
· 2023-01-03
Clinical Trial Update: Role of Oral Lactoferrin in Prevention of Recurnt Bacterial Vaginosis in Pregnancy [Phase 2, Phase 3]
Summary
Phase 2/Phase 3 trial update evaluating oral lactoferrin for prevention of recurrent bacterial vaginosis during pregnancy.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Zagazig University | Conditions: Bacterial Vaginosis | Vaginal | Microbiology | Phase 2, Phase 3 | Status: UNKNOWN